Press Releases.
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
February 05, 2014-Regulus to Develop microRNA-21 for Alport Syndrome, a Life-Threatening Orphan Kidney Disease, and microRNA-21 in Oncology, to Human Proof-of-Concept-
-
February 04, 2014-Mr. Szekeres Brings Extensive Strategic and Transactional Deal Experience-
-
February 03, 2014
-
January 13, 2014-Regulus microMarkers™ Designed to Support Regulus' Therapeutic Pipeline, its Collaborators and Strategic Partners-
-
January 07, 2014
-
December 23, 2013
-
November 13, 2013- Regulatory Application for RG-101 to be Filed in the Near Term: Clinical Studies in Man Expected to Commence in Early 2014 -
-
November 08, 2013- New Survival Data Presented at Kidney Week 2013 -
-
November 04, 2013- Late-Breaking Poster to be Presented at AASLD -
-
August 13, 2013-'Road to the Clinic' Strategy On Track; Preparing for Clinical Development of RG-101 for HCV; Second microRNA Clinical Candidate to be Nominated by Year End -
-
June 24, 2013Include multimedia assets in your release for better visibility
-
May 14, 2013- Nominated RG-101 in HCV as First microRNA Candidate for Clinical Development-
-
April 01, 2013Industry Legend Brings Deep Biotechnology Expertise
-
February 20, 2013-Progressed Partnered and Proprietary microRNA Programs-
-
February 04, 2013
-
January 31, 2013Mr. Foletta Brings Extensive Financial and Commercial Biotechnology Expertise
-
January 03, 2013
-
December 20, 2012
-
December 03, 2012
-
November 19, 2012-Formed Multiple Strategic Relationships to Support our microRNA-based Therapeutics and Biomarker Platforms-
-
November 08, 2012
-
November 07, 2012Stanley T. Crooke, M.D., Ph.D. and Barry E. Greene to Step Down
-
November 03, 2012-Regulus, in partnership with Sanofi, is developing novel anti-fibrotic therapies targeting microRNAs-
-
October 04, 2012
-
August 15, 2012- Initial focus on discovery of microRNAs as biomarkers for multiple sclerosis (MS) -
-
August 14, 2012Focused on three exclusive microRNA targets
-
April 23, 2012- Japan Patent Office Joins Australian, European and U.S. Patent Offices in Granting Claims for Therapeutic Use of Inhibiting microRNA-122 for HCV Treatment
-
February 16, 2012-New study published in Science Translational Medicine demonstrates microRNA-21 contributes to fibrogenesis in the kidney
-
January 05, 2012-New Pre-clinical Data to be Presented on Proprietary Therapeutic Programs in Metabolic Disease and Cancer at Keystone Symposium and AACR Special Conference
-
December 12, 2011-Regulus, Accelerate Brain Cancer Cure (ABC2) and Samsung Medical Center to Advance microRNA Therapeutics for Glioblastoma -
-
November 08, 2011-Regulus Scientists to Provide Update on Lead Therapeutic Program at American Society of Nephrology Meeting-
-
November 02, 2011-The Australia Patent Office Joins the U.S. and European Patent Offices in Granting Claims for Inhibiting microRNA-122 to Reduce Viral Load-